BIOVOX secures 2.2 million euros in seed financing round

Darmstadt-based start-up BIOVOX receives fresh capital to advance sustainable plastics for the healthcare sector. The innovative materials reduce CO2 emissions by up to 85 percent.

Darmstadt, September 25, 2024 -The Darmstadt-based startup BIOVOX has successfully closed a seed financing round of 2.2 million euros. The round was led by High-Tech Gründerfonds (HTGF), with participation from other investors including Beteiligungs-Managementgesellschaft Hessen mbH (BMH) and members of the business angel club better ventures. The fresh capital will help the company to further develop and market its sustainable bioplastics solutions for the healthcare sector.

Sustainable plastics in the healthcare sector

BIOVOX produces bio-based plastics that have been specially developed for the medical sector. These materials reduce CO2 emissions by up to 85 percent compared to conventional plastics based on fossil raw materials. They are used for a variety of applications, including medical disposables, packaging, surgical instruments and endoscopy devices.

Now we have the financial resources to better support our customers in developing a more environmentally friendly product range that is ready for the circular economy. This is how we create full traction for sustainable plastics in the healthcare sector.

Dr.-Ing. Julian Lotz, Managing Director BIOVOX GmbH

BIOVOX bioplastics meet the strictest regulatory requirements and are biocompatible and safe for use in medicine. They help to meet the growing ecological challenges in the healthcare sector. The use of plastics is widespread in the industry, but contributes significantly to global greenhouse gas emissions.

Growth thanks to fresh financing

BIOVOX plans to use the new financing to accelerate its growth. The company wants to set up its own technical center and expand its sales team to meet the increasing demand for environmentally friendly solutions."Our sustainable products are attracting a lot of interest and the additional funding will allow us to expand our offering," explains Julian Lotz, CEO of BIOVOX.

Since its foundation in 2021, BIOVOX has acquired more than 50 customers from the medical technology industry who rely on the company's environmentally friendly materials. The first product has already been successfully launched on the market.

Strong support from investors

Investors are also convinced of BIOVOX's potential. Tilmann Petersen, Investment Manager at HTGF, praises the company as a visionary in the field of sustainable plastics for the life science sector. BIOVOX's innovative solutions could make an important contribution to reducing CO2 emissions in the healthcare sector.

With BIOVOX, we are funding a team of visionaries whose technological brilliance and deep understanding of regulatory affairs is revolutionizing the development of sustainable plastics for the life science industry.

Tilmann Petersen, Investment Manager HTGF

With its sustainable focus and innovative products, BIOVOX is positioning itself as a pioneer in the market for medical bioplastics. The latest financing round is intended to help drive forward the development of environmentally friendly alternatives in the healthcare sector.